Atrion (Atrion) Total Liabilities

: $17.9 Mil (As of Dec. 2023)

View and export this data going back to 1972. Start your Free Trial

Atrion's Total Liabilities for the quarter that ended in Dec. 2023 was $17.9 Mil.

Atrion's quarterly Total Liabilities declined from Jun. 2023 ($25.91 Mil) to Sep. 2023 ($24.63 Mil) and declined from Sep. 2023 ($24.63 Mil) to Dec. 2023 ($17.94 Mil).

Atrion's annual Total Liabilities increased from Dec. 2021 ($22.97 Mil) to Dec. 2022 ($25.17 Mil) but then declined from Dec. 2022 ($25.17 Mil) to Dec. 2023 ($17.94 Mil).

Atrion Total Liabilities Historical Data

The historical data trend for Atrion's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrion Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

24.16

26.45

22.97

25.17

17.94

Atrion Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities																25.17	22.79	25.91	24.63	17.94

Atrion Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Atrion's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12.621	+	(0	+	2.944
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	2.371	+	0)
	=	17.9

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	260.825	-	242.889
	=	17.9

Atrion's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12.621	+	(0	+	2.944
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	2.371	+	0)
	=	17.9

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	260.825	-	242.889
	=	17.9

Atrion Total Liabilities Related Terms

Thank you for viewing the detailed overview of Atrion's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Atrion (Atrion) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Atrion Corp (NAS:ATRI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Allentown Parkway, Allen, TX, USA, 75002-4211

Website

https://www.atrioncorp.com

Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.

Executives

Preston G Athey	director	ONE ALLENTOWN PKWY, ALLEN TX 75002
David A Battat	officer: President & CEO	2700 HALKEY-ROBERTS PLACE NORTH, ST. PETERSBURG FL 33716-4103
Jeannette Bankes	director	ONE ALLENTOWN PARKWAY, ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Morgan Hugh J Jr	director
Ronald Nicholas Spaulding	director	ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Cindy Ferguson	officer: Officer/ CFO	ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Jeffery Strickland	officer: Vice President & CFO
Emile A Battat	director, officer: Chairman	ONE ALLENTOWN PARKWAY, ALLEN TX 75002
Maria Sainz	director	C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Stupp John P Jr	director	STUPP JOHN P JR, #18 ST. ANDREWS DR., ST LOUIS MO 63124
Roger F Stebbing	director
Ronald N Spaulding	director	C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Richard O Jacobson	director	ONE ALLENTOWN PARKWAY, C/O ATRION, ALLEN TX 75002
Maley John H P	director	6 ROCK CREST LANE, SIGNAL MOUNTAIN TN 37377
Margaret Maxwell Zagel	director	C/O TELLABS OPERATIONS INC, 4951 INDIANA AVE, LISLE IL 60532